Division of Pediatric Hematology and Oncology

Drake Robideau, 7, puts his handprint on a car with the help of Nashville SC mascot Tempo during the Hyundai Hope on Wheels check presentation and handprint ceremony. (photo by Erin O. Smith)

Hyundai Hope on Wheels award bolsters pediatric cancer research

Since 2007, Hyundai Hope on Wheels, which includes funding from Hyundai Motor America and local dealerships, has awarded more than $2 million in funding to pediatric cancer researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

Michael DeBaun receives Paragon Award from the Doris Duke Charitable Foundation

Vanderbilt’s Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Multi-institutional study finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.

Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center

Being treated for childhood cancer set Jason Schwartz on the path to his life’s work: treating childhood cancer

Cancer at the age of 13 forced him to give up his dream of professional football. While undergoing treatment, he found a new dream.

1 2 3 5